Empery Asset Management »

Cellectar Biosciences shares owned by Empery Asset Management

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $527k 190k 2.78

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Nervgen Pharma Ord (NGEN)
Precision Biosciences Com New (DTIL)
Clene Com New (CLNN)
Annovis Bio (ANVS)
Lantern Pharma (LTRN)
Amc Entmt Hldgs Cl A New (AMC)
Tenaya Therapeutics (TNYA)
One And One Green Technologi Usd Cl A Ord Shs (YDDL)
Cyngn Inc Com Par $0 00001 (CYN)
Venu Hldg Corp (VENU)
Greenland Energy *w Exp 04/21/203
Ur-energy (URG)
Satellos Bioscience (MSLE)

View all positions for Empery Asset Management

Top funds holding Cellectar Biosciences

Caligan Partners
Stempoint Capital
Vanguard Capital Management
Silverarc Capital Management
Bleichroeder
Jupiter Topco
Balyasny Asset Management
Nantahala Capital Management
Empery Asset Management
Diadema Partners
Stonepine Capital Management
Persistent Asset Partners
Boothbay Fund Management
Geode Capital Management
Vanguard Fiduciary Trust

View all funds holding Cellectar Biosciences